Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study
Clinical trial NCT07522762 · RECRUITING
Trial details
- NCT number
- NCT07522762
- Sponsor
- The Netherlands Cancer Institute
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-05-21
- Primary completion
- 2027-05-21
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.